Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry

F. van de Watering, M. Rijpkema, M. Robillard, W. Oyen and O. Boerman

64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats

K. Mikkola, M. Kirsi, C. Yim, Y. Cheng-Bin, V. Fagerholm, F. Veronica, T. Ishizu, I. Tamiko, V. Elomaa, E. Viki-Veikko, J. Rajander, R. Johan, J. Jurttila, J. Jori, T. Saanijoki, S. Tiina, T. Tolvanen, T. Tuula, M. Tirri, T. Marko, E. Gourni, G. Eleni, M. Béhé, B. Martin, M. Gotthardt, G. Martin, J. Reubi, R. Claude, H. Mäcke, M. Helmut, A. Roivainen, R. Anne, O. Solin, S. Olof, P. Nuutila and N. Pirjo

Optimizing lutetium 177-anti-carbonic anhydrase IX radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model

C. Muselaers, E. Oosterwijk, D. Bos, W. Oyen, P. Mulders and O. Boerman

Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma

C. Muselaers, A. Stillebroer, I. Desar, M. Boers-Sonderen, C. van Herpen, M. de Weijert, J. Langenhuijsen, E. Oosterwijk, W. Leenders, O. Boerman, P. Mulders and W. Oyen

Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab

C. Muselaers, A. Stillebroer, M. Rijpkema, G. Franssen, E. Oosterwijk, P. Mulders, W. Oyen and O. Boerman

Response to comment by Aprile et al.: the EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer

F. Giammarile, N. Alazraki, J. Aarsvold, R. Audisio, E. Glass, S. Grant, J. Kunikowska, M. Leidenius, V. Moncayo, R. Uren, W. Oyen, R. Olmos and S. Sicart

The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers

F. Giammarile, M. Bozkurt, D. Cibula, J. Pahisa, W. Oyen, P. Paredes, R. Olmos and S. Sicart

mTOR Inhibition Promotes TTF1-Dependent Redifferentiation and Restores Iodine Uptake in Thyroid Carcinoma Cell Lines

T. Plantinga, B. Heinhuis, D. Gerrits, M. Netea, L. Joosten, A. Hermus, W. Oyen, R. Schweppe, B. Haugen, O. Boerman, J. Smit and R. Netea-Maier

Beta cell imaging - a key tool in optimized diabetes prevention and treatment

M. Gotthardt, D. Eizirik, M. Cnop and M. Brom

Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome

A. Arens, E. Troost, B. Hoeben, W. Grootjans, J. Lee, V. Grégoire, M. Hatt, D. Visvikis, J. Bussink, W. Oyen, J. Kaanders and E. Visser

Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2$times$Anti-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide

C. van Rij, C. Frielink, D. Goldenberg, R. Sharkey, S. Lütje, W. McBride, W. Oyen and O. Boerman

Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer

W. Grootjans, L. de Geus-Oei, A. Meeuwis, C. van der Vos, M. Gotthardt, W. Oyen and E. Visser

SPECT- and Fluorescence Image-Guided Surgery Using a Dual-Labeled Carcinoembryonic Antigen-Targeting Antibody

M. Rijpkema, W. Oyen, D. Bos, G. Franssen, D. Goldenberg and O. Boerman

Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model

L. Heijmen, E. Ter Voert, C. Punt, A. Heerschap, W. Oyen, J. Bussink, C. Sweep, P. Laverman, P. Span, L. de Geus-Oei, O. Boerman and H. van Laarhoven

PET and SPECT Imaging of a Radiolabeled Minigastrin Analogue Conjugated with DOTA, NOTA, and NODAGA and Labeled with (64)Cu, (68)Ga, and (111)In

S. Roosenburg, P. Laverman, L. Joosten, M. Cooper, P. Kolenc-Peitl, J. Foster, C. Hudson, J. Leyton, J. Burnet, W. Oyen, P. Blower, S. Mather, O. Boerman and J. Sosabowski

Correlation Between In Vivo 18F-FDG PET and Immunohistochemical Markers of Glucose Uptake and Metabolism in Pheochromocytoma and Paraganglioma

A. van Berkel, J. Rao, B. Kusters, T. Demir, E. Visser, A. Mensenkamp, J. van der Laak, E. Oosterwijk, J. Lenders, F. Sweep, R. Wevers, A. Hermus, J. Langenhuijsen, D. Kunst, K. Pacak, M. Gotthardt and H. Timmers

Assessing the Response to Targeted Therapies in Renal Cell Carcinoma: Technical Insights and Practical Considerations

A. Bex, L. Fournier, N. Lassau, P. Mulders, P. Nathan, W. Oyen and T. Powles

Molecular imaging of receptor tyrosine kinases in cancer

S. Heskamp

Dynamics of IGF-1R Expression During Endocrine Breast Cancer Treatment

S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, R. Koornstra, S. Linn, W. Oyen, W. van der Graaf and H. van Laarhoven

Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without altering VEGF expression

S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, F. Sweep, A. Geurts-Moespot, M. Engelhardt, W. van der Graaf, W. Oyen and H. van Laarhoven